Imperial College London

ProfessorRohiniSharma

Faculty of MedicineDepartment of Surgery & Cancer

Professor Clinical Pharmacology and Medical Oncology
 
 
 
//

Contact

 

+44 (0)20 3313 3059r.sharma Website

 
 
//

Location

 

ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Ross:2020,
author = {Ross, PJ and Ma, YT and Palmer, DH and Lythgoe, MP and Merrick, S and Samson, A and Rao, AR and Basu, B and Prasad, D and Dhillon, T and Lau, D and Darby, S and Orr, J and Margetts, J and Hubner, R and Baijal, S and Sharma, R and Faluyi, OO and Lee, L and Thillai, K},
publisher = {AMER SOC CLINICAL ONCOLOGY},
title = {Real-world experience of regorafenib in patients with hepatocellular carcinoma: A multicenter United Kingdom study},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530922700480&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Ross,PJ
AU - Ma,YT
AU - Palmer,DH
AU - Lythgoe,MP
AU - Merrick,S
AU - Samson,A
AU - Rao,AR
AU - Basu,B
AU - Prasad,D
AU - Dhillon,T
AU - Lau,D
AU - Darby,S
AU - Orr,J
AU - Margetts,J
AU - Hubner,R
AU - Baijal,S
AU - Sharma,R
AU - Faluyi,OO
AU - Lee,L
AU - Thillai,K
PB - AMER SOC CLINICAL ONCOLOGY
PY - 2020///
SN - 0732-183X
TI - Real-world experience of regorafenib in patients with hepatocellular carcinoma: A multicenter United Kingdom study
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530922700480&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -